Effectiveness of the New Perilaryngeal Airway in Comparison With the Laryngeal Mask Airway

May 5, 2015 updated by: Amir H Pakpour, Qazvin University Of Medical Sciences

Effectiveness of the New Perilaryngeal Airway (CobraPLA™) in Comparison With the Laryngeal Mask Airway (LMA™) to Improve Oropharyngeal Leak Pressure Among Obese and Overweight Patients

The Laryngeal Mask Airway (LMA) has been used widely for different patients and found to be highly safe for adult and pediatric patients. However, the LMA has some limitations and weaknesses (e.g. more insertion attempts in 5% to 10 % of all cases. Despite the easy insertion of the LMA, it is crucial to check correct placement of the LMA airway.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

74

Phase

  • Phase 4

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • BMI between 25 to 35 kg/m2
  • scheduled for surgery
  • being older than 18 years
  • Mallampati class I-III and BMI between 25 and 35

Exclusion Criteria:

  • pregnancy
  • morbid obese (BMI>35 kg/m2)
  • a known difficult airway
  • gastro-oesophageal reflux
  • pharyngeal pathology
  • emergency operation with full stomach

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CobraPLA
Patients will randomly assign to either LMA or Cobra PLATM
Experimental: LMA
Patients will randomly assign to either LMA or Cobra PLATM

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oropharyngeal leak
Time Frame: Up to 1 hours
Up to 1 hours
Time to intubation
Time Frame: Up to 1 hours
Time to intubation was measured from inserting of the device to the patient's month while connecting the breathing circuit
Up to 1 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
successful intubation attempt
Time Frame: Up to 1 hours
A successful intubation attempt was recognized if: the breathing circuit connected, the EtCO2 trace was revealed, and no air leak was detected at airway pressures of 15 cm H2O
Up to 1 hours
incidence of sore throat
Time Frame: Up to 1 hours
Up to 1 hours
incidence of dysphasia
Time Frame: Up to 1 hours
Up to 1 hours
incidence of postoperative blood staining on mask
Time Frame: Up to 1 hours
Up to 1 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Amir H Pakpour, PhD, Qazvin University of Medical Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2012

Primary Completion (Actual)

January 1, 2013

Study Registration Dates

First Submitted

February 5, 2015

First Submitted That Met QC Criteria

May 5, 2015

First Posted (Estimate)

May 8, 2015

Study Record Updates

Last Update Posted (Estimate)

May 8, 2015

Last Update Submitted That Met QC Criteria

May 5, 2015

Last Verified

May 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • 653

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on COBRA

Subscribe